Korean J Pancreas Biliary Tract.  2024 Jan;29(1):31-34. 10.15279/kpba.2024.29.1.31.

The First Case Report of Ketamine-Induced Cholangiopathy in Korea

Affiliations
  • 1Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea

Abstract

Ketamine is an anesthetic agent for diagnostic and surgical procedures. However, it can produce dissociative anesthesia and induce hallucinations. Therefore, it tends to be abused as a recreational drug. Chronic ketamine use can cause numerous adverse effects including ketamine-induced chlangiopathy and ulcerative cystitis. Ketamineinduced cholangiopathy has been reported since the 1980s and most cases were found in Western countries and South Asia. Here, we report the first case of ketamineinduced cholangiopathy in Korea. Owing to increasing recreational drug use among Koreans, ketamine-induced cholangiopathy should be considered in the differential diagnosis in young patients with cholangitis of unknown etiology.

Keyword

Ketamine; Cholangitis; Substance abuse; 케타민; 담관염; 약물남용
Full Text Links
  • KJPBT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr